Back to Agenda
How to De-Risk Alliances for Success
Session Chair(s)
Candice M Hughes, PHD, MBA
CEO/Founder, Hughes BioPharma Advisers LLC, United States
A significant number of partnerships fail. By going beyond standard practices to de-risk for success pre- and post-partnering, firms can avoid reduced revenue, elevated costs and brand damage due to failed alliances and partnerships. This session will include how to make a go or no go decision plus engagement on an ongoing basis, including periodic checks on milestones and soft targets such as engagement level, communication effectiveness, and others.
Learning Objective : State at least three common causes of partnership failure; Explain hard and soft (such as cultural) due diligence; Describe at least three activities or strategies a sponsor or vendor may use to de-risk a partnership/alliance.
Speaker(s)
Jessica Dero, PMP
Vendor Strategy, Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Candice M Hughes, PHD, MBA
CEO/Founder, Hughes BioPharma Advisers LLC, United States
Alison Schecter, MD, FACC
Global Project Head, Rare Disease, Sanofi, United States
Have an account?
